INNO-GENE SA ZY -10 (WQ3) — Financial Flexibility Index
INNO-GENE SA ZY -10 (WQ3) has a Financial Flexibility Index of 0.09x as of June 2025. Free cash flow of €704.00K (operating CF €54.00K minus capex €650.00K) represents 0% of total liabilities (€7.45 Million). Check INNO-GENE SA ZY -10 (WQ3) asset resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
INNO-GENE SA ZY -10 Financial Flexibility Index (2021–2024)
Historical Financial Flexibility Index trend for INNO-GENE SA ZY -10 across 4 annual periods. See WQ3 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for INNO-GENE SA ZY -10 (2021–2024)
Year-by-year free cash flow to debt coverage for INNO-GENE SA ZY -10. For the full company profile including market capitalisation, see INNO-GENE SA ZY -10 market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.17x | €-1.09 Million | €-1.13 Million | €6.50 Million | ▲ +78.8% |
| 2023 | -0.79x | €-2.49 Million | €-2.49 Million | €3.16 Million | ▼ -15993.0% |
| 2022 | 0.00x | €11.00K | €11.00K | €2.22 Million | ▼ -99.6% |
| 2021 | 1.22x | €6.83 Million | €6.75 Million | €5.60 Million | — |